Skip to main content
. Author manuscript; available in PMC: 2010 May 14.
Published in final edited form as: J Endocrinol. 2007 Feb;192(2):395–403. doi: 10.1677/joe.1.06925

Table 1.

Estradiol (E2)-induced changes in the TSP-1 immunoreactive intensity, in the anterior pituitary (AP), and in CD31-positive vessels in the AP of ovariectomized (Ovx) rats. n=3

Immunoreactive intensity in the AP (arbitrary unit)
Immunoreactive intensity in the CD31-positive vessels (arbitrary unit)
Treatment
Ovx (2 and 4 weeks) +++ ++++
Ovx + E2 (2 weeks) ++ ++/+
Ovx + E2 (4 weeks) ++ +/0